• Home
  • Guillaume Blivet
Guillaume Blivet

Guillaume Blivet
REGEnLIFE · Board of Directors

Master of Public Health

About

8
Publications
564
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
29
Citations
Citations since 2017
8 Research Items
29 Citations
20172018201920202021202220230246810
20172018201920202021202220230246810
20172018201920202021202220230246810
20172018201920202021202220230246810

Publications

Publications (8)
Poster
Full-text available
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer's Disease? Design of a pivotal sham-controlled randomized, double blind, multicentric clinical investigation.
Article
Full-text available
Quantitative phase microscopies (QPMs) enable label-free, non-invasive observation of living cells in culture, for arbitrarily long periods of time. One of the main benefits of QPMs compared with fluorescence microscopy is the possibility to measure the dry mass of individual cells or organelles. While QPM dry mass measurements on neural cells have...
Article
Background: Recent innovative non-pharmacological interventions and neurostimulation devices have shown potential for application in the treatment of Alzheimer's disease (AD). These include photobiomodulation (PBM) therapy. Objective: This pilot study assesses the safety, compliance with, and efficacy of a brain-gut PBM therapy for mild-to-moder...
Article
Full-text available
Introduction Photobiomodulation was assessed as a novel treatment of Alzheimer’s disease (AD) by the use of a new device RGn500 combining photonic and magnetic emissions in a mouse model of AD. Methods Following the injection of amyloid β 25-35 peptide in male Swiss mice, RGn500 was applied once a day for 7 days either on the top of the head or th...

Network

Cited By

Projects

Project (1)